Defective Cd3 Mediated Proliferation and Lps Responsiveness in Multiple Sclerosis

References

• Antel JP, Freedman MS, Brodsovsky S, Francis GS, Duquette P. Activated suppressor cell function in severely diabled patients with multiple sclerosis. Ann Neurol 1989; 25: 204–207
   PubMed Web of Science ®Google Scholar
• McFarlin D, McFarland H. Multiple Sclerosis. N Engl J Med 1982; 307: 1183–1188
   PubMed Web of Science ®Google Scholar
• Kam-Hansen S, Link H, Fryden A, Moller E. Reduced in vitro responsers of CSF lymphocytes to mitogen stimulation in multiple sclerosis. Scand. J. Immunol 1979; 10: 161–169
   Google Scholar
• Stratton JA, Peter JB. The responses of peripheral blood and synovial fluid lymphocytes of patients with rheumatoid arthritis to in vitro stimulation with mitogens. Clin. Immunol. Immunopath 1978; 10: 233–241
   PubMedGoogle Scholar
• Lotz M., Tsoukas CD, Robinson CA, Dinarello CA, Carson DA. Vaughan JH Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 [T3] antibodies. J. Clin. Invest 1986; 78: 713–721
   PubMed Web of Science ®Google Scholar
• Balkwill F. R. Interferons: Their impact in biology of medicine (Taylor-Papadimitriou.). Oxford Medical Publications. 1985; 61–80
   Google Scholar
• Kurtzke JF. Course of exacerbations of multiple sclerosis in hospitalized patients. Arch Neurol Psychiatry 1956; 76: 175–184
   Google Scholar
• Hauser SL, Dawson DM, Lehrich JR. Intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of high dose intravenous cyclophosphamide, plasma exchange and ACTH. N Eng J Med 1983; 308: 173–180
   PubMed Web of Science ®Google Scholar
• Schwinzer R, Franklin RA, Domenico J, Renz H, Gelfand EW. Monoclonal antibodies directed to different epitopes in the CD3-TCR complex can induce different states of competence in resting human T cells. J. Immunol 1992; 148: 1322–1328
   Google Scholar
• Smith KGC, Austyn JM, Hariri G, Beverley PCL, Morris PJ. T cell activation by anti-T cell antibodies: comparison of IgG, and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors. Eur J Immunol 1986; 28: 15–26
   Google Scholar
• Stekman IL, Blasini AM, Leon-Ponte M, Baroja ML, Abadi I, Rodriguez MA. Enhanced CD3-mediated T lymphocyte proliferation in patients with SLE. Arthritis Rheum 1991; 34: 459–467
   PubMed Web of Science ®Google Scholar
• Kaneoka H, Morito F, Yamaguchi M. Low responsiveness to the Leu-4 antibody by T cells from patients with active SLE. J. Clin. Lab. Immunol 1989; 28: 15–26
   Google Scholar
• Hertzog PJ, Wright A, Harris G, Linnane AW, Mackay IR. Intermittent interferonemia and interferon responses in multiple sclerosis. Clin. Immunol. Immunopath 1988; 58: 18–32
   Google Scholar
• Maruo Y. Interferon production and natural killer activity of peripheral blood lymphocytes obtained from patients with multiple sclerosis. Hokkaido J. Med. Sci. 1988; 63: 521–533
   Google Scholar
• Salonen R, Ilonen J, Reunanen M, Nikoskelainen J, Salmi A. PPD-, PWM-, and PHA-induced interferon in stable MS: Association with HLA-Dw2 antigen and clinical variables. Ann. Neurol 1982; 11: 279–284
   Google Scholar
• Kamin-Lewis RM, Panitch HS, Johnson KP. Leucocytes from multiple sclerosis patients respond to α. and γ. interferons. J. Neuroimmunol 1985; 9: 221–227
   Google Scholar
• Kato T, Kitaura M, Inaba K, Wanatabe Y, Kawade Y, Muramatsu S. Suppression of macrophage la antigen expression by endogenous interferon α/β. J. Int. Res. 1989; 9: 393–405
   Google Scholar
• Janeway CA. The Tcell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in Tcell activation. Annu. Rev. Immunol 1992; 10: 645–74
   PubMed Web of Science ®Google Scholar
• Rudd CE, Trevillyan JM, Dasgupta JD, Wong LL, Schloss-Man SF. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. PNAS 1988; 85: 5190–5194
   PubMed Web of Science ®Google Scholar
• Veillette A, Bookman MA, Horak EM, Bolen JB. The CD4 and CD8 Tcell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 1988; 55: 301–308
   PubMed Web of Science ®Google Scholar
• Barber EK, Dasgupta JD, Schlossman SF, Trevillyan JM, Rudd CE. The CD4 and CD8 antigens are coupled to a protein tyrosine kinase (p56lck) that phosphorylates the CD3 complex. PNAS 1989; 86: 3277–3281
   PubMed Web of Science ®Google Scholar
• Tonks NK, Charbonneau H, Diltz CD, Fischer EF, Walsh KA. Demonstration that the leucocyte common antigen CD45 is a protein tyrosine phosphatase. Biochemistry 1988; 27: 8695–8701
   PubMedGoogle Scholar
• Ledbetter JA, Tonks NK, Fischer EH, Clark EA. CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T and B cells. PNAS 1988; 85: 8628–8632
   PubMed Web of Science ®Google Scholar
• Rudd CE, Anderson P, Morimoto C, Streuli M., Schlossman SF. Molecular interaction. T cell subset and a role of the CD4/CD8: p56lck complex in human T cell activation. Immunol. Rev 1989; 111: 225–266
   PubMed Web of Science ®Google Scholar